Last reviewed · How we verify
NCT04794439
Plaque Removal Efficacy of Four Dentifrices Following a Single Brushing
Phase 2 trial testing Dentifrices in Plaque, Dental in 70 participants. Completed in 18 December 2020.
18 December 2020
Quick facts
| Lead sponsor | Church & Dwight Company, Inc. |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 16 November 2020 |
| Primary completion | 18 December 2020 |
| Estimated completion | 18 December 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Dentifrices — full drug profile →
Conditions studied
- Plaque, Dental — all drugs for Plaque, Dental →
Sponsor
Church & Dwight Company, Inc. — full company profile →
Who can join
Adults 18 to 69, any sex, with Plaque, Dental. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate and compare plaque removal efficacy of four dentifrices following a single timed tooth brushing. Prior to each evaluation visit of the four-way cross-over study, subjects will abstain from all oral hygiene for 24 hours. At each evaluation visit, subjects will be given a pre-brushing plaque evaluation, followed by a 1-minute supervised brushing and a post-brushing plaque evaluation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04794439
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dentifrices
Trials testing the same drug.
- NCT03988374 — Clinical Efficacy Evaluation of Three Dentifrices · Phase 2 · completed
Other recruiting trials for Plaque, Dental
Currently open trials in the same condition.
- NCT06017817 — Antibacterial Photodynamic Therapy in the Management of Peri-implantitis · NA · recruiting
- NCT06453005 — Comparative Evaluation of SMART Hall Technique Vs. Conventional SS Crown in Primary Molars: a Randomized Clinical Trial · NA · recruiting
- NCT05965076 — Analysis of the Effectiveness of the Use of Glycine Powder and Angled Implant Brush in Oral Hygiene Maintenance in Patie · NA · recruiting
- NCT05384132 — Novel Dental Gel as an Adjunct to Scaling and Root Planing · NA · recruiting
Other Church & Dwight Company, Inc. trials
Trials by the same sponsor.
- NCT07419763 — Intra Oral Appliance (IOA) Model Evaluating the Efficacy of Sensitive Toothpaste · NA · completed
- NCT07419737 — Dental Plaque Prevention Efficacy of a Stannous Fluoride Toothpaste · NA · completed
- NCT07419685 — Intraoral Appliance (IOA) Model Evaluating the Efficacy of a Whitening Toothpaste · NA · completed
- NCT07425509 — Evaluation of a Stannous Fluoride Dentifrice for Control of Oral Malodor · NA · completed
- NCT07419672 — Intra Oral Application (IOA) Testing Study of a Stannous Toothpaste · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04794439 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Church & Dwight Company, Inc.
- Last refreshed: 12 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04794439.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing